“Trying, But Failing” — The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence

Journal of Allergy and Clinical Immunology: In Practice

Volumn 4, Issue 5, 2016, Pages 823-832

  Braido, Fulvio ^a   Chrystyn, Henry ^b   Baiardini, Ilaria ^a   Bosnic Anticevich, Sinthia ^c,d   van der Molen, Thys ^e   Dandurand, Ronald J ^f   Chisholm, Alison ^g   Carter, Victoria ^h   Price, David ⁱ  

^a UNIVERSITY OF GENOA   (Italy)

^b Research in Real Life   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f MCGILL UNIVERSITY   (Canada)

^g Respiratory Effectiveness Group   (United Kingdom)

^h Unit 5 6   (United Kingdom)

ⁱ UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Adherence; Implementation; Inhaler device; Inhaler technique; Initiation; Patient preference; Persistence

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; SALBUTAMOL; RESPIRATORY TRACT AGENT;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRY POWDER INHALER; HEALTH CARE MANAGEMENT; HEALTH PERSONNEL ATTITUDE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INHALER; MEDICATION COMPLIANCE; METERED DOSE INHALER; PATIENT COMPLIANCE; PATIENT PREFERENCE; PATIENT SATISFACTION; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); HEALTH CARE PERSONNEL; NEBULIZER; PROFESSIONAL STANDARD;

ADMINISTRATION, INHALATION; HEALTH PERSONNEL; HUMANS; MEDICATION ADHERENCE; NEBULIZERS AND VAPORIZERS; PROFESSIONAL ROLE; RESPIRATORY SYSTEM AGENTS;

EID: 84992091977     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2016.03.002     Document Type: Conference Paper

References (56)

1. 1 Global Initiative for Asthma. 2015 GINA Report, Global Strategy for Asthma Management and Prevention. 2015. Available from: http://ginasthma.org/gina-report-global-strategy-for-asthma-management-and-prevention/. Accessed December 28, 2015.
2. 2 Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD – 2016. Available from: http://www.goldcopd.org/Guidelines/guidelines-resources.html. Accessed December 28, 2015.
3. 3 Inhaler Error Steering Committee, Price, D., Bosnic-Anticevich, S., Briggs, A., Chrystyn, H., Rand, C., Scheuch, G., et al. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med 107 (2013), 37–46.
4. 4 Yawn, B.P., Colice, G.L., Hodder, R., Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J Chron Obstruct Pulmon Dis 7 (2012), 495–502.
5. 5 Lavorini, F., Corrigan, C.J., Barnes, P.J., Dekhuijzen, P.R.N., Levy, M.L., Pedersen, S., et al. Retail sales of inhalation devices in European countries: so much for a global policy. Respir Med 105 (2011), 1099–1103.
6. 6 Laube, B.L., Janssens, H.M., de Jongh, F.H., Devadason, S.G., Dhand, R., Diot, P., et al., European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 37 (2011), 1308–1331.
7. 7 Dima, A.L., de Bruin, A., Van Ganse, E., ASTRO-LAB group. Mapping the asthma care process: implications for research and practice. J Allergy Clin Immunol Pract 4 (2016), 868–876.
8. 8 Vrijens, B., De Geest, S., Huges, D.A., Przemyslaw, K., Demonceau, J., Ruppar, T., et al., ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73 (2012), 691–705.
9. 9 Fischer, M.A., Stedman, M.R., Lii, J., Vogeli, C., Shrank, W.H., Brookhart, M.A., et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 25 (2010), 284–290.
10. 10 Restrepo, R.D., Alvarez, M.T., Wittnebel, L.D., Sorenson, H., Wettstein, R., Vines, D.L., et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 3 (2008), 371–384.
11. 11 Lareau, S.C., Yawn, B.P., Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis 5 (2010), 401–406.
12. 12 Cole, S., Seale, C., Griffiths, C., ‘The blue one takes a battering’ why do young adults with asthma overuse bronchodilator inhalers? A qualitative study. BMJ Open, 3, 2013, e002247.
13. 13 Price, D., David-Wang, A., Ho, J.C.-M., Jeong, J.W., Liam, C.K., Lin, J., et al., REALISE Asia Working Group. Time for a new language for asthma control: results from REALISE Asia. J Asthma Allergy 8 (2015), 93–103.
14. 14 Price, D., Musgrave, S.D., Shepstone, L., Hillyer, E.V., Sims, E.J., Gilbert, R.F., et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 364 (2011), 1695–1707.
15. 15 Ovchinikova, L., Smith, L., Bosnic-Anticevich, S., Inhaler technique maintenance: gaining an understanding from the patient's perspective. J Asthma 48 (2001), 616–624.
16. 16 Cochrane, M.G., Bala, M.V., Downs, K.E., Mauskopf, J., Ben-Joseph, R.H., Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 117 (2000), 542–550.
17. 17 Bailey, W.C., Richards, J.M. Jr., Brooks, C.M., Soong, S.J., Windsor, R.A., Manzella, B.A., A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med 150 (1990), 1664–1668.
18. 18 Giraud, V., Roche, N., Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 19 (2002), 246–251.
19. 19 Goodman, D., Israel, E., Rosenberg, M., Johnston, R., Weiss, S.T., Drazen, J.M., The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med 150 (1994), 1256–1261.
20. 20 Crompton, G.K., Barnes, P.J., Broeders, M., Corrigan, C., Corbetta, L., Dekhuijzen, R., et al., Aerosol Drug Management Improvement Team. The need to improve inhalation technique in Europe: a report by the Aerosol Drug Management Improvement Team. Respir Med 100 (2006), 1479–1494.
21. 21 Chinet, T., Huchon, G., Misuse of pressurized metered dose aerosols in the treatment of bronchial diseases: incidence and clinical consequences [in French]. Ann Med Interne (Paris) 145 (1994), 119–124.
22. 22 van der Palen, J., Klein, J.J., van Herwaarden, C.L.A., Multiple inhalers confuse asthma patients. Eur Respir J 14 (1999), 1034–1037.
23. 23 Chrystyn, H., Ryan, D., Gruffydd-Jones, K., Haughney, J., Roche, N., Lavorini, F., et al., iHARP steering committee. HARP (Helping Asthma In Real People) project: improving patient care globally (Abstract 11). Pragmatic Obs Res 6 (2015), 13–38.
24. 24 Price D. Assessment of potentially important device errors performed by asthma patients in the global iHARP review service. Presented at: International Primary Care Respiratory Group Congress; May 21-24, 2014; Athens, Greece. http://www.theipcrg.org/download/attachments/12386457/OR-100.pdf?. Accessed March 30, 2016.
25. 25 Westerik, J.A.M., Carter, V., Chrystyn, H., Burden, A., Thompson, S.L., Ryan, D., et al. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma 53 (2016), 321–329.
26. 26 Price, D., Harrow, B., Small, M., Pike, J., Higgins, V., Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J, 8, 2015, 26.
27. 27 Chrystyn, H., Small, M., Milligan, G., Higgins, V., Garcia Gil, E., Estruch, J., Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med, 108, 2014, 358e365.
28. 28 Doyle, S., Lloyd, A., Williams, A., Chrystyn, H., Moffat, M., Thomas, M., et al. What happens to patients who have their asthma device switched without their consent?. Prim Care Respir J 19 (2010), 131–139.
29. 29 Rossi, A., van der Molen, T., del Olmo, R., Papi, A., Wehbe, L., Quinn, M., et al. INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. Eur Respir J 44 (2014), 1548–1555.
30. 30 Hanada, S., Wada, S., Ohno, T., Sawaguchi, H., Muraki, M., Tohda, Y., Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. Int J Chron Obstruct Pulmon Dis 6 (2015), 69–77.
31. 31 Thomas, M., Price, D., Chrystyn, H., Lloyd, A., Williams, A.E., von Ziegenweidt, J., Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulm Med, 9, 2009, 1.
32. 32 Yu, A.P., Guérin, A., Ponce de Leon, D., Ramakrishnan, K., Wu, E.Q., Mocarski, M., et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. J Med Econ 14 (2011), 486–496.
33. 33 Price, D., Chrystyn, H., Kaplan, A., Haughney, J., Román-Rodríguez, M., Burden, A., et al. Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res 4 (2012), 184–191.
34. 34 Horne, R., Price, D., Cleland, J., Costa, R., Covey, D., Gruffydd-Jones, K., et al. Can asthma control be improved by understanding the patient's perspective?. BMC Pulm Med, 7, 2007, 8.
35. 35 Price, D., Robertson, A., Bullen, K., Rand, C., Horne, R., Staudinger, H., Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. BMC Pulm Med, 10, 2010, 1.
36. 36 Price, D., Lee, A.J., Sims, E.J., Kemp, L., Hillyer, E.V., Chisholm, A., et al. Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study. Prim Care Respir J 22 (2013), 161–168.
37. 37 Ingersoll, K.S., Cohen, J., The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 31 (2008), 213–224.
38. 38 Conn, K.M., Halterman, J.S., Lynch, K., Cabana, M.D., The impact of parents’ medication beliefs on asthma management. Pediatrics 120 (2007), e521–e526.
39. 39 Ponieman, D., Wisnivesky, J.P., Leventhal, H., Musumeci-Szabo, T.J., Halm, E.A., Impact of positive and negative beliefs about inhaled corticosteroids on adherence in inner-city asthmatic patients. Ann Allergy Asthma Immunol 103 (2009), 38–42.
40. 40 Menckeberg, T.T., Bouvy, M.L., Bracke, M., Kaptein, A.A., Leufkens, H.G., Raaijmakers, J.A., et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 64 (2008), 47–54.
41. 41 Barnes, P.J., Jonsson, B., Klim, J.B., The costs of asthma. Eur Respir J 9 (1996), 636–642.
42. 42 Bahadori, K., Doyle-Waters, M.M., Marra, C., Lynd, L., Alasaly, K., Swiston, J., et al. Economic burden of asthma: a systematic review. BMC Pulm Med, 9, 2009, 24.
43. 43 George, J., Kong, D.C., Thoman, R., Stewart, K., Factors associated with medication nonadherence in patients with COPD. Chest 128 (2005), 3198–3204.
44. 44 Dalal, A.A., Shah, M., D'Souza, A.O., Rane, P., Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med 105 (2011), 454–460.
45. 45 van Grunsven, P.M., van Schayck, C.P., van Deuveren, M., van Herwaarden, C.L., Akkermans, R.P., van Weel, C., Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) study. J Asthma 37 (2000), 225–234.
46. 46 van Boven, J.F.M., Ryan, D., Eakin, M.N., Canonica, G.W., Barot, A., Foster, J.M., et al. Enhancing respiratory medication adherence: the role of health care professionals and cost-effectiveness considerations. J Allergy Clin Immunol Pract 4 (2016), 835–846.
47. 47 Grover, C., Armour, C., Asperen, P.P., Moles, R., Saini, B., Medication use in children with asthma: not a child size problem. J Asthma 48 (2011), 1085–1103.
48. 48 Braido, F., Baiardini, I., Blasi, F., Pawankar, R., Canonica, G.W., Adherence to asthma treatments: ‘we know, we intend, we advocate’. Curr Opin Allergy Clin Immunol 15 (2015), 49–55.
49. 49 Plaza, V., Sanchis, J., Roura, P., Molina, J., Calle, M., Quirce, S., et al. Physicians’ knowledge of inhaler devices and inhalation techniques remains poor in Spain. J Aerosol Med Pulm Drug Deliv 25 (2012), 16–22.
50. 50 Hanania, N.A., Wittman, R., Kesten, S., Chapman, K.R., Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 105 (1994), 111–116.
51. 51 Fink, J.B., Rubin, B.K., Problems with inhaler use: a call for improved clinician and patient education. Respir Care 50 (2005), 1360–1374.
52. 52 Nguyen, Y.B.N., Wainwright, C., Basheti, I.A., Willis, M., Bosnic-Anticevich, S.Z., Do health professionals on respiratory wards know how to use inhalers?. J Pharm Pract Res 40 (2010), 211–216.
53. 53 World Allergy Organization. Manifesto on adherence to asthma treatment in respiratory allergy. Available from: http://www.worldallergy.org/UserFiles/file/GWCManifestoAdherenceChicago_fullpage.pdf. Accessed December 28, 2015.
54. 54 Cramer, J.A., Roy, A., Burrell, A., Fairchild, C.J., Fuldeore, M.J., Ollendorf, D.A., et al. Medication compliance and persistence: terminology and definitions. Value Health 11 (2008), 44–47.
55. 55 McCarney, R., Warner, J., Iliffe, S., van Haselen, R., Griffin, M., Fisher, P., The Hawthorne effect: a randomised, controlled trial. BMC Med Res Methodol, 3, 2007, 30.
56. 56 Costello, R.W., Foster, J.M., Grigg, J., Eakin, M.N., Canonica, W., Yunus, F., et al. The seven stages of man: the role of developmental stage on medication adherence in respiratory diseases. J Allergy Clin Immunol Pract 4 (2016), 813–820.